2XW logo

Curaleaf Holdings, Inc.DB:2XW Stock Report

Market Cap €2.2b
Share Price
n/a
1Yn/a
7D-8.3%
1D-9.2%
Portfolio Value
View

Curaleaf Holdings, Inc.

DB:2XW Stock Report

Market Cap: €2.2b

2XW Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW501,452 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
501,452 investors already sharing narratives

Curaleaf Holdings, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Curaleaf Holdings
Historical stock prices
Current Share PriceCA$8.00
52 Week HighCA$10.02
52 Week LowCA$5.22
Beta1.64
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO22.07%

Recent News & Updates

Recent updates

Shareholder Returns

2XWDE PharmaceuticalsDE Market
7D-8.3%0.1%2.0%
1Yn/a47.3%1.2%

Return vs Industry: Insufficient data to determine how 2XW performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 2XW performed against the German Market.

Price Volatility

Is 2XW's price volatile compared to industry and market?
2XW volatility
2XW Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.5%
10% most volatile stocks in DE Market12.6%
10% least volatile stocks in DE Market2.8%

Stable Share Price: 2XW's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 2XW's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a5,554Boris Jordanwww.curaleaf.com

Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway.

Curaleaf Holdings, Inc. Fundamentals Summary

How do Curaleaf Holdings's earnings and revenue compare to its market cap?
2XW fundamental statistics
Market cap€2.17b
Earnings (TTM)-€99.17m
Revenue (TTM)€1.13b
1.9x
P/S Ratio
-22.0x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2XW income statement (TTM)
RevenueUS$1.29b
Cost of RevenueUS$653.00m
Gross ProfitUS$632.75m
Other ExpensesUS$745.95m
Earnings-US$113.21m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Aug 05, 2026

Earnings per share (EPS)-0.43
Gross Margin49.21%
Net Profit Margin-8.80%
Debt/Equity Ratio85.1%

How did 2XW perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 06:38
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Curaleaf Holdings, Inc. is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Frederico Yokota Choucair GomesATB Cormark
Kenric TygheCanaccord Genuity